Is overweight an issue in phenylketonuria?

Area of Science:

• Metabolic disorders
• Nutritional science
• Pediatric endocrinology

Background:

• Dietary management in phenylketonuria (PKU) is crucial for metabolic control but may be linked to increased obesity risk.
• While early studies suggested a tendency for overweight in PKU, recent findings are mixed, with a notable increase in obesity among female patients.
• Limited data exists on the metabolic consequences of obesity specifically within the PKU population.

Purpose of the Study:

• To review the current understanding of obesity risk and its implications in individuals with phenylketonuria (PKU).
• To highlight challenges in interpreting existing research and identify gaps in knowledge regarding obesity etiology and consequences in PKU.
• To emphasize the role of PKU management teams in preventing and monitoring overweight and obesity.

Main Methods:

• Literature review of studies investigating overweight and obesity in phenylketonuria (PKU).
• Analysis of factors contributing to variability in published results, including patient age, dietary approaches, adherence, and metabolic control.
• Comparison of PKU population data with general population data, acknowledging international variations.

Main Results:

• Inconsistencies exist in published data regarding the prevalence of overweight and obesity in PKU.
• Obesity in PKU may stem from the condition itself, treatment side effects, or suboptimal metabolic control.
• Specific treatment strategies, phenylalanine targets, and PKU severity can influence nutritional intake and weight development.

Conclusions:

• Further investigation is essential to clarify the relationship between PKU, its treatment, and obesity.
• Effective strategies for treating obesity in PKU patients have not been established.
• Comprehensive nutritional monitoring, attention to feeding behaviors, and promoting exercise are vital for preventing overweight and obesity in individuals with PKU.